Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pfizer Inc (NYSE:PFE)

35.43
Delayed Data
As of Nov 22
 0.00 / 0.00%
Today’s Change
30.51
Today|||52-Week Range
36.78
+9.08%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Operating ActivitiesNet Income / Starting Line866.0M3.1B3.1B2.9B
 
 
 
 
 
Depreciation1.5B1.6B1.6B1.6B
 
 
 
 
 
Total Other Cash Flow1.1B-907.0M-56.0M333.0M
 
 
 
 
 
Funds From Operations4.2B3.8B4.9B4.7B
 
 
 
 
 
Funds From/For Other Operating Expenses-1.8B2.2B1.6B-209.0M
 
 
 
 
 
Net Cash Flow - Operating Activities6.0B1.6B3.3B4.9B
 
 
 
 
 
 
InvestingIncrease In Investments-8.2B-1.4B-2.6B-4.9B
 
 
 
 
 
Decrease In Investments6.6B6.9B1.6B2.5B
 
 
 
 
 
Capital Expenditures-689.0M-358.0M-448.0M-450.0M
 
 
 
 
 
Net Assets From Acquisitions -689.0M-585.0M-415.0M0.00
 
 
 
 
Other Investing - Sources-8.0M297.0M158.0M64.0M
 
 
 
 
 
Net Cash Flow Investing-3.1B4.8B-1.7B-3.0B
 
 
 
 
 
 
FinancingShort Term Borrowings-2.8B-2.1B2.0B-83.0M
 
 
 
 
 
Long Term Borrowings5.9B5.3B0.000.00
 
 
 
Long Term Debt Reduction-3.4B-1.3B-3.2B-1.0M
 
 
 
 
 
Net Proceeds Stock Sale73.0M313.0M98.0M245.0M
 
 
 
 
 
Common Preferred Redeemed0.00-5.0B0.000.00
 
 
Common Dividends----------
Cash Dividends Paid - Total-1.8B-1.9B-1.9B-1.9B
 
 
 
 
 
Other Sources - Financing----------
Other Uses - Financing--220.0M8.0M-5.0M
 
 
 
 
Net Cash Flow - Financing-2.2B-4.9B-3.0B-1.7B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-136.0M21.0M16.0M30.0M
 
 
 
 
 
 
Net Change In Cash638.0M1.4B-1.5B163.0M